A New Era for FOXG1: The Race to First‑in‑Human Trials

FOXG1 Research Foundation CEO Nasha Fitter returns to Sounds of Science with extraordinary updates: FDA Fast Track designation, IND clearance, and the first‑ever clinical trial for a FOX G1 gene therapy now within reach. In this episode, hear how science, community, and a mother’s determination are rewriting what’s possible. 

 Show Notes 

• Cell and Gene Therapy CDMO Solutions | Charles River 
• Viral Vector Manufacturing \ Charles River 
• AAV Production for Rare Disease Therapies: From Challenge to Solution | Webcast 
• Rare Disease | Charles River 
• Rare Disease Research for Drug Development | Charles River 
• FOX G1: A Mom’s Mission | Podcast